{
"info": {
"nct_id": "NCT00696072",
"official_title": "Randomized Phase II Trial of Letrozole With or Without Dasatinib as First and Second-line Treatment for Hormone Receptor-positive, HER2-negative Post-menopausal Breast Cancer That is Unresectable, Locally Recurrent or Metastatic",
"inclusion_criteria": "* Has histologic or cytologic diagnosis of breast cancer; evidence of unresectable locally recurrent or metastatic disease\n* Has measurable or evaluable-only disease\n* Is female, ≥18 yrs of age, post menopausal or surgically sterile\n* HER2 negative, HR+, ER+ and/or PgR+ breast cancer\n* 0-1 prior chemotherapy regimen for metastatic disease.\n* Prior adjuvant or neoadjuvant chemotherapy completed at least 1 month prior\n* Prior tamoxifen therapy is allowed\n* No AI therapy for >1 year without recurrence\nHealthy volunteers allowed\nMust be FEMALE\nMust have minimum age of 18 Years",
"exclusion_criteria": "* Pregnant or breast feeding\n* Prior hormonal therapy for metastatic or locally recurrent disease\n* >1 chemotherapy regimen for metastatic disease\n* Pleural or pericardial effusion\n* Serious cardiac condition",
"miscellaneous_criteria": "For more information regarding BMS clinical trial participation, please visit www.BMSStudyConnect.com."
},
"inclusion_lines": [
{
"line": "* Has histologic or cytologic diagnosis of breast cancer; evidence of unresectable locally recurrent or metastatic disease",
"criterions": [
{
"exact_snippets": "Has histologic or cytologic diagnosis of breast cancer",
"criterion": "breast cancer diagnosis",
"requirements": [
{
"requirement_type": "method",
"expected_value": [
"histologic",
"cytologic"
]
}
]
},
{
"exact_snippets": "evidence of unresectable locally recurrent or metastatic disease",
"criterion": "disease status",
"requirements": [
{
"requirement_type": "presence",
"expected_value": "unresectable locally recurrent or metastatic"
}
]
}
]
},
{
"line": "* Has measurable or evaluable-only disease",
"criterions": [
{
"exact_snippets": "measurable or evaluable-only disease",
"criterion": "disease measurability",
"requirements": [
{
"requirement_type": "type",
"expected_value": [
"measurable",
"evaluable-only"
]
}
]
}
]
},
{
"line": "* Is female, ≥18 yrs of age, post menopausal or surgically sterile",
"criterions": [
{
"exact_snippets": "Is female",
"criterion": "gender",
"requirements": [
{
"requirement_type": "value",
"expected_value": "female"
}
]
},
{
"exact_snippets": "≥18 yrs of age",
"criterion": "age",
"requirements": [
{
"requirement_type": "minimum",
"expected_value": {
"operator": ">=",
"value": 18,
"unit": "yrs"
}
}
]
},
{
"exact_snippets": "post menopausal",
"criterion": "menopausal status",
"requirements": [
{
"requirement_type": "status",
"expected_value": "post menopausal"
}
]
},
{
"exact_snippets": "surgically sterile",
"criterion": "reproductive status",
"requirements": [
{
"requirement_type": "status",
"expected_value": "surgically sterile"
}
]
}
]
},
{
"line": "* HER2 negative, HR+, ER+ and/or PgR+ breast cancer",
"criterions": [
{
"exact_snippets": "HER2 negative",
"criterion": "HER2 status",
"requirements": [
{
"requirement_type": "status",
"expected_value": "negative"
}
]
},
{
"exact_snippets": "HR+",
"criterion": "hormone receptor status",
"requirements": [
{
"requirement_type": "status",
"expected_value": "positive"
}
]
},
{
"exact_snippets": "ER+",
"criterion": "estrogen receptor status",
"requirements": [
{
"requirement_type": "status",
"expected_value": "positive"
}
]
},
{
"exact_snippets": "PgR+",
"criterion": "progesterone receptor status",
"requirements": [
{
"requirement_type": "status",
"expected_value": "positive"
}
]
}
]
},
{
"line": "* 0-1 prior chemotherapy regimen for metastatic disease.",
"criterions": [
{
"exact_snippets": "0-1 prior chemotherapy regimen for metastatic disease",
"criterion": "prior chemotherapy regimen for metastatic disease",
"requirements": [
{
"requirement_type": "quantity",
"expected_value": {
"comparisons": [
{
"operator": ">=",
"value": 0,
"unit": "N/A"
},
{
"operator": "<=",
"value": 1,
"unit": "N/A"
}
]
}
}
]
}
]
},
{
"line": "* Prior adjuvant or neoadjuvant chemotherapy completed at least 1 month prior",
"criterions": [
{
"exact_snippets": "Prior adjuvant or neoadjuvant chemotherapy",
"criterion": "adjuvant or neoadjuvant chemotherapy",
"requirements": [
{
"requirement_type": "completion",
"expected_value": true
}
]
},
{
"exact_snippets": "completed at least 1 month prior",
"criterion": "time since chemotherapy completion",
"requirements": [
{
"requirement_type": "duration",
"expected_value": {
"operator": ">=",
"value": 1,
"unit": "month"
}
}
]
}
]
},
{
"line": "* Prior tamoxifen therapy is allowed",
"criterions": [
{
"exact_snippets": "Prior tamoxifen therapy is allowed",
"criterion": "tamoxifen therapy",
"requirements": [
{
"requirement_type": "prior use",
"expected_value": true
}
]
}
]
},
{
"line": "* No AI therapy for >1 year without recurrence",
"criterions": [
{
"exact_snippets": "AI therapy for >1 year without recurrence",
"criterion": "AI therapy",
"requirements": [
{
"requirement_type": "duration",
"expected_value": {
"operator": ">",
"value": 1,
"unit": "year"
}
},
{
"requirement_type": "recurrence",
"expected_value": false
}
]
}
]
},
{
"line": "Healthy volunteers allowed",
"criterions": [
{
"exact_snippets": "Healthy volunteers allowed",
"criterion": "volunteer health status",
"requirements": [
{
"requirement_type": "status",
"expected_value": "healthy"
}
]
}
]
},
{
"line": "Must be FEMALE",
"criterions": [
{
"exact_snippets": "Must be FEMALE",
"criterion": "gender",
"requirements": [
{
"requirement_type": "expected_value",
"expected_value": "female"
}
]
}
]
},
{
"line": "Must have minimum age of 18 Years",
"criterions": [
{
"exact_snippets": "minimum age of 18 Years",
"criterion": "age",
"requirements": [
{
"requirement_type": "minimum",
"expected_value": {
"operator": ">=",
"value": 18,
"unit": "Years"
}
}
]
}
]
}
],
"exclusion_lines": [
{
"line": "* Pregnant or breast feeding",
"criterions": [
{
"exact_snippets": "Pregnant",
"criterion": "pregnancy",
"requirements": [
{
"requirement_type": "presence",
"expected_value": false
}
]
},
{
"exact_snippets": "breast feeding",
"criterion": "breastfeeding",
"requirements": [
{
"requirement_type": "presence",
"expected_value": false
}
]
}
]
},
{
"line": "* Prior hormonal therapy for metastatic or locally recurrent disease",
"criterions": [
{
"exact_snippets": "Prior hormonal therapy for metastatic or locally recurrent disease",
"criterion": "hormonal therapy",
"requirements": [
{
"requirement_type": "prior treatment",
"expected_value": true
}
]
},
{
"exact_snippets": "metastatic or locally recurrent disease",
"criterion": "disease status",
"requirements": [
{
"requirement_type": "type",
"expected_value": [
"metastatic",
"locally recurrent"
]
}
]
}
]
},
{
"line": "* >1 chemotherapy regimen for metastatic disease",
"criterions": [
{
"exact_snippets": ">1 chemotherapy regimen for metastatic disease",
"criterion": "chemotherapy regimen",
"requirements": [
{
"requirement_type": "quantity",
"expected_value": {
"operator": ">",
"value": 1,
"unit": "N/A"
}
}
]
}
]
},
{
"line": "* Pleural or pericardial effusion",
"criterions": [
{
"exact_snippets": "Pleural or pericardial effusion",
"criterion": "pleural effusion",
"requirements": [
{
"requirement_type": "presence",
"expected_value": true
}
]
},
{
"exact_snippets": "Pleural or pericardial effusion",
"criterion": "pericardial effusion",
"requirements": [
{
"requirement_type": "presence",
"expected_value": true
}
]
}
]
},
{
"line": "* Serious cardiac condition",
"criterions": [
{
"exact_snippets": "Serious cardiac condition",
"criterion": "cardiac condition",
"requirements": [
{
"requirement_type": "severity",
"expected_value": "serious"
}
]
}
]
}
],
"miscellaneous_lines": [],
"failed_inclusion": [],
"failed_exclusion": [],
"failed_miscellaneous": [
{
"line": "For more information regarding BMS clinical trial participation, please visit www.BMSStudyConnect.com.",
"criterions": []
}
]
}